Arkolith/Insider Trading/APYX/Form 4

Goodwin Charles D. II

Chief Executive Officer, DirectorApyx Medical Corp (APYX) · full profile →Form 4 · filed Aug 31, 2022
Net Buying
Open-Market Buys
$70K
Open-Market Sells
$0
Net Open-Market Flow
$70K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 29, 2022Buy(P)10K$5.97$58K40K
Aug 29, 2022Buy(P)2K$5.93$12K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000719135-22-000084) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Apyx Medical Corp

Build

Ask your agent about APYX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000719135-22-000084"
Ask your agent
Use Arkolith to summarize insider buying and selling at Apyx Medical Corp
over the last 90 days and cite the filings.